Invention Grant
- Patent Title: Gene expression profiling of EGFR positive cancer
- Patent Title (中): EGFR阳性癌基因表达谱
-
Application No.: US13150799Application Date: 2011-06-01
-
Publication No.: US08148076B2Publication Date: 2012-04-03
- Inventor: Joffre B. Baker , Maureen T. Cronin , Steven Shak , Jose Baselga
- Applicant: Joffre B. Baker , Maureen T. Cronin , Steven Shak , Jose Baselga
- Applicant Address: US CA Redwood City
- Assignee: Genomic Health, Inc.
- Current Assignee: Genomic Health, Inc.
- Current Assignee Address: US CA Redwood City
- Agency: Bozicevic, Field & Francis LLP.
- Agent Paula A. Borden
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12M1/34 ; C07H21/02 ; C07H21/04
Abstract:
The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
Public/Granted literature
- US20110245102A1 Gene Expression Profiling of EGFR Positive Cancer Public/Granted day:2011-10-06
Information query
